Saint Louis Heart and Vascular PC
St Louis, Missouri 63136
1 studies enrolling now · 3 studies all time
What they study most
ASCVD, Atherosclerotic Cardiovascular Disease, Obesity, Overweight
Studies at this site
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early